When the vaccine drops to ~50% efficacy, what does it mean in practice? This is how I interpret it.

when a vaccine is ~50% effective it does not mean "breakthrough" infection will be 50% less severe.

No, it means that out of 100 vaccinated, 50 will be protected & 50 will not
The problem with such efficacy is that one cannot know in which "50" group one is: protected group or unprotected group.

In practice, it means that when one is vaccinated but the vaccine drops to ~50% efficacy, a given individual can be 100% protected or 0% protected.
Now, let's analyze what we know about current vaccines. Multiple studies reported that by ~ 6 months post 2-dose vaccination (and starting at 3 months) vaccine efficacy drops and reaches below 50%

nejm.org/doi/full/10.10…
So, at ~6 months, an individual with 2-dose vaccination may be 100% protected or 0% protected but no way to tell in which group one ends up. This applies to both documented infections and hospitalizations.
Now comes 3rd dose. What is its efficacy? It is also less than 50%.

What does it mean? It means that ~ 6 months, half of the 2-dose vaccinated people will be completely unprotected and after 3rd dose, again, half of them will be or stay unprotected.

medrxiv.org/content/10.110…
The most difficult part is that no way to tell if one is in a protected or unprotected group after 6 months or after 3rd dose. It's the toss of the dice if a given individual is protected or not when the vaccine shows 50% or less efficacy (after 3rd dose).
So, what can be done? Right now, the vaccines we have provide only a short window of protection (~3 months) and it appears 3rd dose effect is random (50/50). Unless something changes, think of #Mask and #SocialDistancing as something absolutely essential.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with David Usharauli

David Usharauli Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @3DiMMUNE

12 Sep
I see people are still debating what is the level of protection from 2-dose vaccine against symptomatic #covid19.Enough studies now show at ~6 months post vaccination it is <50% efficacy and frequently close 0%,meaning without masks rate of infection is the same for vax/unvax 1/
but protection against severe/death is still good at 6 months (~70% efficacy).

But due to the uncertain nature of the level of Ab titers and its waning speed, immune priming or failing, and underlying conditions, is it better to wear the masks pretty much constantly outside 2/
some may ask how long should we wear the mask or social distance?

with first-generation #COVID19 vaccines, based on their efficacy, how they work, how long, it will be unrealistic to expect we could go back to pre-2020 behavior, even with 100% vaccination rates.

3/
Read 8 tweets
4 Sep
immunologically speaking, there no rhyme or reason to believe that if 2-dose vaccine-induced neut Abs hang around for 6 months, somehow they will hang around much longer after 3rd dose. 1/
in general, it is quite unexpected that after such robust 2-dose antigen priming, as mRNA vaccine does (based on Ab titers immediately after 2nd dose), we should see such a precipitous drop in vaccine efficacy within 6 months. 2/
everyone pays attention to neut Ab titers but even NIH/Moderna's own study in lab mice showed neut Abs are not essential at all. These were confirmed in a more recent study using B cell KO mice. No Ab is needed to protect mice against #SARSCoV2.

3/
Read 9 tweets
13 Aug
Recently, we published the concluding part III of the #SPIRAL model, which we were working on since 2016.

Pathological T Helper Polarization Requires Pre-existing Cross-Reactive Memory T Cells

I'm going to explain the significance of this model.

preprints.org/manuscript/202…
In part I published in 2018, we introduced the SPIRAL model. It proposes that cross-reactivity is the basic unit that drives the evolution of adaptive immune system and it is thymus-derived regulatory T cells, Tregs, that rely on cross-reactive epitopes to control other T cells
We also proposed that thymus-derived #Foxp3 Tregs rely on #CrossReactive epitope derived from the friendly gut microbiota to survive and function in the periphery. So one of the main roles of gut microflora is to supply #Tregs with epitopes.

onlinelibrary.wiley.com/doi/10.1111/sj…
Read 16 tweets
28 Jul
These two graphs tells the story about 3rd wave with #DeltaVariant.

daily cases vs. daily death. Based on data from 2nd wave,we should have expected already ~ 500-2000 death daily but so far the UK only reported ~ 100 daily death. Does it mean vaccine worked? No. why not?

1/
Why cannot I say with certainty that 10-20 fold lower daily deaths in the 3rd wave indicate that the vaccine is effective?

Simply because the authority consistently say that >90% of those who are diagnosed with #COVID19 are non-vaccinated.

2/
So, >90% with #COVID19 are non-vaccinated and still there is 10-20 fold fewer daily death?

This makes no sense unless #COVID19 positive population in 3rd wave is completely different from those in the 1st and 2nd waves.

3/
Read 5 tweets
28 Jan
We are entering a new, endemic stage of #COVID19 spread. Drop in efficacy (50% or less) against new SA variants is a classical example of vaccine efficacy against #influenza virus.
It is clear from all available data that both @BioNTech_Group and @moderna_tx mRNA vaccines will be less effective against SA variant and there will be many more like this.
@BioNTech_Group @moderna_tx but we will have a bigger problem than SA variant of #SARS_CoV_2. And it has to do with the little-understood phenomenon of "original antigenic sin" [OAS]. The idea that @moderna_tx or @BioNTech_Group will simply design new #mRNA #vaccines against SA variant, will not work here.
Read 6 tweets
19 Jan
In this opinion paper @RMedzhitov went back to drawing board to update his views on #allergy and how it could develop.

#immunology

I read this paper and here is my take on it

1/
@RMedzhitov Why focus on allergy? b/c allergy is a paradox. The allergy we recognize is a completely maladaptive response and has no protective role whatsoever. It is not clear why do we even need IgE

2/
@RMedzhitov So, some 10 years ago or so, @RMedzhitov started to suggest that #allergy is an intrinsic property of a certain type of #antigens, many of them with enzymatic function (enzymes). 3/
Read 24 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(